Cargando…

Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM

Detalles Bibliográficos
Autores principales: Anakok, O.F., Kose, P., Bayindirli, K.N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/
http://dx.doi.org/10.1016/S1465-3249(23)00636-9
_version_ 1785039345056481280
author Anakok, O.F.
Kose, P.
Bayindirli, K.N.
author_facet Anakok, O.F.
Kose, P.
Bayindirli, K.N.
author_sort Anakok, O.F.
collection PubMed
description
format Online
Article
Text
id pubmed-10171031
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101710312023-05-10 Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM Anakok, O.F. Kose, P. Bayindirli, K.N. Cytotherapy POSTER ABSTRACTS: Gene Editing/Gene Therapies International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023-05 2023-05-10 /pmc/articles/PMC10171031/ http://dx.doi.org/10.1016/S1465-3249(23)00636-9 Text en Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER ABSTRACTS: Gene Editing/Gene Therapies
Anakok, O.F.
Kose, P.
Bayindirli, K.N.
Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title_full Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title_fullStr Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title_full_unstemmed Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title_short Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM
title_sort gene editing/gene therapies: bioreactor recombinant production of sars-cov-2 virus antigens in cho cell clones by using new ucoe lentiviral vector system
topic POSTER ABSTRACTS: Gene Editing/Gene Therapies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/
http://dx.doi.org/10.1016/S1465-3249(23)00636-9
work_keys_str_mv AT anakokof geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem
AT kosep geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem
AT bayindirlikn geneeditinggenetherapiesbioreactorrecombinantproductionofsarscov2virusantigensinchocellclonesbyusingnewucoelentiviralvectorsystem